维普期刊资源整合服务平台（V6.5）

40篇 您的检索式：作者名="SEIWERT TY"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The MET receptor tyrosine is a potential novel therapeutic target for head and neck squamous cell carcinoma显示文摘	SEIWERT TY JAGADEESWARAN R FAORO F	2009	Cancer Res2009，69，7：	1
2	A phase Istudy of pemetrexed,carboplatin, and concurrent radio-therapy inpatients with locally advanced or metastatic non-small cell lung or esophageal cancer显示文摘	Seiwert TY Connell PP Mauer AM	2007	Clin Cancer Res2007，13，21：	1
3	The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma显示文摘	Seiwert TY Jagadeeswaran R Faoro L	2009	Cancer Res2009，69，7：	1
4	State-of-the-art management of locally advanced head and neck cancer 显示文摘	Seiwert TY Cohen EE	2005	Br J Cancer2005，92，8：	1
5	Molecular targeted therapies in head and neck cancer an update of recent developments 显示文摘	Goerner M Seiwert TY Sudhoff H	2010	Head Neck Oncol2010，，2：	1
6	C, efitinib re- spense of erlotinih-refractory lung cancer involving menin- ges-role of EGFR mutation 显示文摘	Choong NW Dietrich S Seiwert TY et O2	2006	Nat Clin Pract Oncol2006，3，：	1
7	State-of-the-art management of locally advanced head and neck cancer显示文摘	Seiwert TY Cohen EE	2005	BrJ Cancer2005，92，8：	1
8	A phase I study of pem-etrexed ,carboplatin, and concurrent radiotherapy in patientswith locally advanced or metastatic non-small cell lung or e-sophageal cancer 显示文摘	Seiwert TY Connell PP Mauer AM	2007	Clin Cancer Res2007，13，21：	1
9	State-of-the-art management of locally advanced head and neck cancer显示文摘	Seiwert TY Cohene EW		0，，：	1
10	Gefitinib response of erlotinib-refractory lung cancer involving meninges-role of EGFR mutation显示文摘	CHOONG NW DIETRICH S SEIWERT TY	2006	Nat Clin Pract Oncol2006，3，1：	1
11	The concurrent chemoradiation paradigm--general principles 显示文摘	Seiwert TY Salama JK Vokes EE	2007	Nat Clin Pract Oncol2007，4，2：	1
12	A phase I study of peme- trexed, carboplatin, and conncurrent radiotherapy in patients with lacally advanced or metastatic non-small cell lung or esophageal cancer 显示文摘	Seiwert TY Connell PP Mauer AM	2007	Clin Cancer Res2007，13，21：	1
13	State-of-the-art management of lo- cally advanced head and neck cancer 显示文摘	Seiwert TY Cohen EE	2005	Br J Cancer2005，92，8：	1
14	Gefitinib response of erlotinib - refractory lung cancer involvingmeninges - role of EGFR mutation显示文摘	Choong NW Dietrich S Seiwert TY	2006	Nat Clin Pract Oncol2006，3，：	1
15	Phase I study of bevacizumab added to fluorouracil-and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer显示文摘	Seiwert TY Haraf D J Cohen EE	2008	J Clin Oncol2008，26，10：	1
16	A randomized, phase II study of afatinib versus eetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck 显示文摘	Seiwert TY Fayette J Cupissol D	2014	Ann Oncd2014，25，9：	1
17	Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation显示文摘	Choong NW Dietrich S Seiwert TY ctal	2006	Nat Clin Pract Oncol2006，3，1：	1
18	The concurrent chemoradiation paradigm-general principles显示文摘	Seiwert TY Salama JK Vokes EE		0，，02：	1
19	The concurrent ehemoradb ation paradigm-general principles显示文摘	Seiwert TY Salama JK Vokes EE	2007	Nat Clin Pract Oncol2007，4，2：	1
20	The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma 显示文摘	Seiwert TY Jagadeeswaran R Faro L	2009	Cancer Res2009，69，7：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示